IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 199 filers reported holding IMPAX LABORATORIES INC in Q3 2016. The put-call ratio across all filers is 1,411.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $12,787,000 | -14.9% | 443,691 | -5.4% | 0.23% | -10.1% |
| Q1 2016 | $15,025,000 | -42.5% | 469,250 | -23.2% | 0.26% | -39.7% |
| Q4 2015 | $26,124,000 | -2.9% | 610,940 | -20.0% | 0.43% | +0.2% |
| Q3 2015 | $26,892,000 | -29.6% | 763,760 | -8.2% | 0.43% | -17.4% |
| Q2 2015 | $38,194,000 | -22.9% | 831,740 | -21.3% | 0.52% | -13.7% |
| Q1 2015 | $49,527,000 | +101.5% | 1,056,680 | +36.2% | 0.60% | +108.7% |
| Q4 2014 | $24,574,000 | – | 775,700 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |